(Reuters) - The Cambridge, Massachusetts-based biotechnology company
posted a net loss of $117.8 million, or 91 cents per share,
compared with a loss of $77.7 million, or 72 cents per share, a
year ago.
Excluding items, Vertex lost 74 cents per share, 5 cents
more than analysts' average expectations, according to Reuters
Estimates.
Read more at Reuters.com Market News
posted a net loss of $117.8 million, or 91 cents per share,
compared with a loss of $77.7 million, or 72 cents per share, a
year ago.
Excluding items, Vertex lost 74 cents per share, 5 cents
more than analysts' average expectations, according to Reuters
Estimates.
Read more at Reuters.com Market News
No comments:
Post a Comment